Supramaximal Doses of Botulinum Toxin for Refractory Blepharospasm

Ophthalmology

Volumn 113, Issue 9, 2006, Pages 1665-1668

  Levy, Richard L ^a   Berman, Dalia ^a   Parikh, Mona ^a   Miller, Neil R ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN;

ADULT; AGED; ARTICLE; BLEPHAROSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZATION; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES;

EID: 33747873328     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.03.055     Document Type: Article

References (14)

1. Huang W., Foster J.A., and Rogachefsky A.S. Pharmacology of botulinum toxin. J Am Acad Dermatol 43 (2000) 249-259
2. Frueh B.R., Felt D.P., Wojno T.H., and Musch D.C. Treatment of blepharospasm with botulinum toxin. a preliminary report. Arch Ophthalmol 102 (1984) 1464-1468
3. Scott A.B., Kennedy R.A., and Stubbs H.A. Botulinum A toxin injection as a treatment for blepharospasm. Arch Ophthalmol 103 (1985) 347-350
4. Miller N.R. Essential blepharospasm, Meige syndrome, atypical blepharospasm, and hemifacial spasm. In: Johnson R.T., and Griffin J.W. (Eds). Current Therapy in Neurologic Disease. 5th ed (1997), Mosby, St. Louis 296-302
5. Costa J., Espirito-Santo C., Borges A., et al. Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev 1 (2005) CD004900
6. Jankovic J., and Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 45 (1995) 1743-1746
7. Dutton J.J., and Buckley E.G. Long-term results and complications of botulinum A toxin in the treatment of blepharospasm. Ophthalmology 95 (1988) 1529-1534
8. Lindeboom R., De Haan R., Aramideh M., et al. The Blepharospasm Disability Scale. an instrument for the assessment of functional health in blepharospasm. Mov Disord 10 (1995) 444-449
9. Aoki K.R. Pharmacology and immunology of botulinum toxin type A. Clin Dermatol 21 (2003) 476-480
10. Scott A.B., and Suzuki D. Systemic toxicity of botulinum toxin by intramuscular injection in the monkey. Mov Disord 3 (1988) 333-335
11. Snow B.J., Tsiu J.K., Bhatt M.H., et al. Treatment of spasticity with botulinum toxin. a double-blind study. Ann Neurol 28 (1990) 12-15
12. Greene P., Fahn S., and Diamond B. Development of resistance to botulinum toxin type A in patients with torticollis. Mov Disord 9 (1994) 213-217
13. Siatkowski R.M., Tyutyunikov A., Biglan A.W., et al. Serum antibody production to botulinum A toxin. Ophthalmology 100 (1993) 1861-1866
14. Hanley J.A., and Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 249 (1983) 1743-1745